EC Number   |
KM Value [mM] |
KM Value Maximum [mM] |
Substrate |
Reference |
|---|
   2.4.1.41 | -999 |
- |
apomucin |
13.6 +/-1.9 mg/ml, mutant F303L, 2.8 times higher than wild-type |
686681 |
| 2.4.1.41 | -999 |
- |
apomucin |
17.4 +/-3.6 mg/ml, mutant W316Y, 3.6 times higher than wild-type |
686681 |
| 2.4.1.41 | -999 |
- |
apomucin |
4.7 +/-0.1 mg/ml, truncated wild-type P-T1/delta42 |
686681 |
| 2.4.1.41 | -999 |
- |
apomucin |
43.9 +/-3.8 mg/ml, mutant W316F, 9.1 times higher than wild-type |
686681 |
| 2.4.1.41 | -999 |
- |
apomucin |
5.0 +/-0.2 mg/ml, mutant Y302L |
686681 |
| 2.4.1.41 | -999 |
- |
apomucin |
6.7 +/-1.7 mg/ml, mutant F325L, 1.4 times higher than wild-type |
686681 |
| 2.4.1.41 | -999 |
- |
apomucin |
7.1 +/-0.4 mg/ml, mutant Y309L, 1.5 times higher than wild-type |
686681 |
| 2.4.1.41 | -999 |
- |
GT[GalNAc]TPSPVPTTST[GalNAc]TSAP |
KM >2 mM |
719570 |
| 2.4.1.41 | -999 |
- |
more |
- |
489169, 489172, 489178, 489192 |
| 2.4.1.41 | -999 |
- |
more |
effect of substrate glycosylation and amino acid substitution of glycopeptides on Km-values and enzyme activity |
489176 |
